Topics
Glioblastoma | Treatment | Clinical trials | Tumor treating fields
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Tumor treating fields
Goldlust SA, Singer S, Cappello LA, AlMekkawi AK, Lee KD, Ingenito
AC, Lewis BE, Nyirenda T, Azmi H, Kaptain GJ.
Phase
1 study of concomitant tumor treating fields and temozolomide
chemoradiation for newly diagnosed glioblastoma.
Neurooncol
Adv. 2024 Jul 29;6(1):vdae129. doi:
10.1093/noajnl/vdae129. PMID:
39211521. Interventional study.ˍ
Chen D, Le SB, Ghiaseddin AP, Manektalia H, Li M, O'Dell A, Rahman
M, Tran DD.
Efficacy and safety of
adjuvant TTFields plus pembrolizumab and temozolomide in newly
diagnosed glioblastoma: A phase 2 study.
Med.
2025 Jun 3:100708. doi:
10.1016/j.medj.2025.100708. PMID:
40466642. Interventional study. ˍ